Skip to main content

Trevi Therapeutics, Inc.

TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001563880

In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q2 2023

Institutional positions in Trevi Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
+17 vs. Q1 2023
Shares held
48.8M
+5.36M (+12.3%) vs. Q1 2023
Total value
$116.7M
+$36.3M (+45.1%) vs. Q1 2023
New holders
22
16 more added
Sold out
5
8 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 53 institutions
Q1 2021: 19 institutionsQ2 2021: 17 institutionsQ3 2021: 18 institutionsQ4 2021: 17 institutionsQ1 2022: 23 institutionsQ2 2022: 32 institutionsQ3 2022: 40 institutionsQ4 2022: 37 institutionsQ1 2023: 36 institutionsQ2 2023: 53 institutionsQ3 2023: 55 institutionsQ4 2023: 63 institutionsQ1 2024: 80 institutionsQ2 2024: 77 institutionsQ3 2024: 93 institutionsQ4 2024: 110 institutionsQ1 2025: 137 institutionsQ2 2025: 154 institutionsQ3 2025: 164 institutionsQ4 2025: 184 institutionsQ1 2026: 198 institutionsQ2 2026: 218 institutions
Value heldQ2 2023: $116.7M
Q1 2021: $35.6MQ2 2021: $28.1MQ3 2021: $17.4MQ4 2021: $10.3MQ1 2022: $32.9MQ2 2022: $80.8MQ3 2022: $70.5MQ4 2022: $83.3MQ1 2023: $80.4MQ2 2023: $116.7MQ3 2023: $106.1MQ4 2023: $70.0MQ1 2024: $177.9MQ2 2024: $166.6MQ3 2024: $194.1MQ4 2024: $329.5MQ1 2025: $554.3MQ2 2025: $627.2MQ3 2025: $1.18BQ4 2025: $1.63BQ1 2026: $1.61BQ2 2026: $2.76B
Institutions holding TRVI and their total value by quarter
QuarterHoldersValue
Q2 2026218$2.76B
Q1 2026198$1.61B
Q4 2025184$1.63B
Q3 2025164$1.18B
Q2 2025154$627.2M
Q1 2025137$554.3M
Q4 2024110$329.5M
Q3 202493$194.1M
Q2 202477$166.6M
Q1 202480$177.9M
Q4 202363$70.0M
Q3 202355$106.1M
Q2 202353$116.7M
Q1 202336$80.4M
Q4 202237$83.3M
Q3 202240$70.5M
Q2 202232$80.8M
Q1 202223$32.9M
Q4 202117$10.3M
Q3 202118$17.4M
Q2 202117$28.1M
Q1 202119$35.6M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding TRVI in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
NEA Management Company, LLC11,370,376$27.2M2.07%00.0%Unchanged
Frazier Life Sciences Management, L.P.6,881,090$16.4M0.98%+217,500+3.3%Added
Rubric Capital Management LP5,684,420$13.6M0.58%00.0%Unchanged
Fairmount Funds Management LLC5,190,360$12.4M1.75%−506,155−8.9%Reduced
Viking Global Investors LPSuperinvestorViking Global Investors4,400,000$10.5M0.04%00.0%Unchanged
VR Adviser, LLC3,422,397$8.18M1.31%+372,375+12.2%Added
BlackRock Inc.2,234,861$5.34M0.00%+2,152,616+2,617.3%Added
Vanguard Group Inc1,913,262$4.57M0.00%+413,511+27.6%Added
Opaleye Management Inc.1,701,500$4.07M0.97%+865,700+103.6%Added
MAI Capital Management1,534,652$3.67M0.05%−65,763−4.1%Reduced
Silverarc Capital Management, LLC885,924$2.12M0.71%00.0%Unchanged
Geode Capital Management, LLC778,821$1.86M0.00%+530,528+213.7%Added
State Street Corp680,593$1.63M0.00%+581,051+583.7%Added
Northern Trust Corp321,557$768.5K0.00%+257,374+401.0%Added
Bridgeway Capital Management, LLC186,481$445.7K0.01%−1,919−1.0%Reduced
Tejara Capital Ltd180,227$430.7K0.21%−9,991−5.3%Reduced
J. Goldman & Co LP137,873$329.5K0.02%+48,685+54.6%Added
Bank of New York Mellon Corp131,867$315.2K0.00%+117,769+835.4%Added
Trust Co of Toledo NA124,857$298.4K0.05%+41,857+50.4%Added
Charles Schwab Investment Management Inc107,707$257.4K0.00%+95,150+757.7%Added
PFS Partners, LLC100,000$239.0K0.20%+100,000New
WealthTrust Axiom LLC93,500$223.5K0.07%00.0%Unchanged
Renaissance Technologies LLC89,300$213.0K0.00%−148,100−62.4%Reduced
Nuveen Asset Management, LLC66,935$160.0K0.00%+66,935New
Citadel Advisors LLC60,453$144.5K0.00%−11,202−15.6%Reduced
Rhumbline Advisers50,057$119.6K0.00%+50,057New
Innovis Asset Management LLC43,232$103.3K0.04%−44,137−50.5%Reduced
Atom Investors LP38,377$91.7K0.03%+3,906+11.3%Added
Morgan Stanley37,791$90.3K0.00%+37,407+9,741.4%Added
Bank of America Corp37,590$89.8K0.00%+37,590New
New York State Common Retirement Fund36,300$86.8K0.00%+36,300New
Goldman Sachs Group Inc35,051$83.8K0.00%+35,051New
JPMorgan Chase & Co33,174$79.3K0.00%+33,174New
United Bank28,450$68.0K0.01%00.0%Unchanged
UBS Group AG24,055$57.5K0.00%+16,475+217.3%Added
American International Group, Inc.20,037$47.9K0.00%+20,037New
Voya Investment Management LLC17,460$41.7K0.00%+17,460New
Invesco Ltd.16,046$38.4K0.00%+16,046New
Wells Fargo & Company15,837$37.9K0.00%+15,572+5,876.2%Added
Barclays PLC14,052$33.6K0.00%+14,052New
California State Teachers Retirement System13,848$33.1K0.00%+13,848New
Citigroup Inc12,398$29.6K0.00%+12,398New
Susquehanna International Group, LLP11,571$27.7K0.00%−16,095−58.2%Reduced
BNP Paribas Arbitrage, SA10,849$25.9K0.00%+10,849New
LPL Financial LLC10,000$23.9K0.00%00.0%Unchanged
Zacks Investment Management10,000$23.9K0.00%+10,000New
STRS Ohio8,700$20.0K0.00%+8,700New
Amalgamated Bank4,049$10.0K0.00%+4,049New
Royal Bank of Canada4,343$10.0K0.00%+4,343New
Legal & General Group Plc3,974$9.50K0.00%+3,974New
Ameritas Investment Partners, Inc.3,438$8.22K0.00%+3,438New
Tower Research Capital LLC (TRC)1,502$3.59K0.00%+1,502New
FMR LLC886$2.12K0.00%+886New
Millennium Management LLC0$00.00%−59,628−100.0%Sold out
Bailard, Inc.0$00.00%−21,200−100.0%Sold out
Two Sigma Investments, LP0$00.00%−12,928−100.0%Sold out
Squarepoint Ops LLC0$00.00%−11,474−100.0%Sold out
Simplex Trading, LLC0$00.00%−10−100.0%Sold out